9IVV
 
 | | Crystal structure of human secretory glutaminyl cyclase in complex with the inhibitor 3-((2-(1H-imidazol-5-yl)ethyl)carbamoyl)-4-amino-1,2,5-oxadiazole 2-oxide (compound 13) | | Descriptor: | 4-azanyl-~{N}-[2-(1~{H}-imidazol-4-yl)ethyl]-2-oxidanidyl-1,2,5-oxadiazol-2-ium-3-carboxamide, DIMETHYL SULFOXIDE, DIMETHYLFORMAMIDE, ... | | Authors: | Li, G.-B, Yu, J.-L, Zhou, C, Ning, X.-L, Mou, J, Wu, J.-W, Meng, F.-B. | | Deposit date: | 2024-07-24 | | Release date: | 2025-03-12 | | Last modified: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (2.961 Å) | | Cite: | Knowledge-guided diffusion model for 3D ligand-pharmacophore mapping.
Nat Commun, 16, 2025
|
|
9ISD
 | | Crystal structure of human secretory glutaminyl cyclase in complex with the inhibitor N-(1H-benzo[d]imidazol-5-yl)-1-phenylmethanesulfonamide (compound 5) | | Descriptor: | DI(HYDROXYETHYL)ETHER, DIMETHYL SULFOXIDE, DIMETHYLFORMAMIDE, ... | | Authors: | Li, G.-B, Yu, J.-L, Zhou, C, Ning, X.-L, Mou, J, Wu, J.-W, Meng, F.-B. | | Deposit date: | 2024-07-17 | | Release date: | 2025-03-12 | | Last modified: | 2025-03-19 | | Method: | X-RAY DIFFRACTION (2.367 Å) | | Cite: | Knowledge-guided diffusion model for 3D ligand-pharmacophore mapping.
Nat Commun, 16, 2025
|
|
